<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01942902</url>
  </required_header>
  <id_info>
    <org_study_id>2013.01.CE</org_study_id>
    <nct_id>NCT01942902</nct_id>
  </id_info>
  <brief_title>A Comparative Study to Evaluate the Accuracy and Safety of the GlySure Continuous Intravascular Glucose Monitoring System Versus Intermittent Blood Glucose Monitoring</brief_title>
  <official_title>A Comparative Study to Evaluate the Accuracy and Safety of the GlySure Continuous Intravascular Glucose Monitoring System Versus Intermittent Blood Glucose Monitoring Using the Yellow Springs Blood Glucose Analyser for Conformité Européenne (CE) Marking Purposes in a Total of Thirty Patients Admitted to The Surgical Intensive Care Unit (SICU)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlySure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlySure</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the system performance of the GlySure Continuous
      Glucose Monitoring (CGM) system in patients admitted to the Surgical Intensive Care Unit.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of the CGM system as compared with the Yellow Springs Instrument (YSI) blood sample analysis results</measure>
    <time_frame>For at least 30 hours and up to 7 days</time_frame>
    <description>The study is designed to evaluate the comparative accuracy between measured blood glucose results obtained from the GlySure Continuous Glucose Monitoring System (CGM) and the YSI, and to determine if any condition or treatment affects the sensor's measured values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants experiencing Serious Adverse Events (SAEs) causally related to the devices</measure>
    <time_frame>For at least 30 hours and up to 7 days</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Continuous Glucose Measurement</condition>
  <arm_group>
    <arm_group_label>Continuous Glucose Monitoring System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous Glucose Monitoring System</intervention_name>
    <arm_group_label>Continuous Glucose Monitoring System</arm_group_label>
    <other_name>Glysure</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient or legal representative MUST be willing to sign an informed consent document

          2. Male and female aged 18 years and above

          3. Require Central Venous Catheter (CVC) into the right internal Jugular vein as part of
             disease management and treatment

          4. Expected to remain in the Surgical Intensive Care Unit (SICU) for at least 30 hours
             and up to 7 days-

        Exclusion Criteria:

          1. Patient or legal representative unable to provide written informed consent

          2. Patient who is pregnant

          3. Patient who is currently being administered Mannitol

          4. Patient with history of Pulmonary Embolism (PE)

          5. Patient with history of thrombosis

          6. Patient with known hyper-coagulation

          7. Patient with known history of heparin hypersensitivity

          8. Patient with history of heparin induced thrombocytopenia

          9. Participation in a clinical study involving an unlicensed pharmaceutical product
             and/or device within the 3 months prior to enrolment in this study

         10. Patient with known hypersensitivity/allergy to adhesive I.V. dressings such as 3M
             Tegaderm film

         11. Patient likely to require an MRI scan during their stay in the SICU

         12. Patients likely to require treatment with Mannitol during time in the SICU
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krishna Prasad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Care Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Star Hospital</name>
      <address>
        <city>Banjara Hills</city>
        <state>Hyderabad</state>
        <zip>500034</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Care Hospital</name>
      <address>
        <city>Nampally</city>
        <state>Hyderabad</state>
        <zip>500001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2013</study_first_submitted>
  <study_first_submitted_qc>September 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2013</study_first_posted>
  <last_update_submitted>November 5, 2013</last_update_submitted>
  <last_update_submitted_qc>November 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

